Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.59 USD | +3.60% | +10.21% | +11.16% |
04/04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
29/02 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.16% | 35.25M | |
+26.01% | 661B | |
+26.74% | 566B | |
-6.72% | 352B | |
+19.46% | 332B | |
+3.46% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.29% | 145B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics : Northland Adjusts VYNE Therapeutics' Price Target to $6 From $12, Keeps Outperform Rating